DRTSW icon

Alpha Tau Medical Warrant

1.00 USD
+0.05
5.26%
At close Updated Apr 17, 4:00 PM EDT
1 day
5.26%
5 days
21.6%
1 month
4.17%
3 months
28.21%
6 months
210.08%
Year to date
170.27%
1 year
334.78%
5 years
104.08%
10 years
104.08%
 

About: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Employees: 121

0
Funds holding %
of 8,118 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™